Subclinical Immune Checkpoint Inhibitor-Induced Myocarditis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Subclinical Immune Checkpoint Inhibitor-Induced Myocarditis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedNot Applicable

NCT06566209

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

The purpose of this pilot study is to evaluate Fluorodeoxyglucose - Positron Emission Tomography (FDG-PET) as an imaging modality to diagnose and risk stratify…

United States2 participantsStarted 2024-10-11

Treatment: Fluorodeoxyglucose - Positron Emission Tomography (FDG-PET)